Secretary to the Authority Dr. David Nahamya and team met UNICEF Uganda’s Country Coordinator Dr.Munir Safieldin and his team
NDA BOARD CHAIRPERSON DR. MEDARD BITEKYEREZO AND SECRETARY TO THE AUTHORITY, DR. DAVID NAHAMYA WITH MEMBERS OF THE 11TH PARLIAMENT ON THE HEALTH COMMITTEE WHILE VISITING NATIONAL DRUG AUTHORITY
CONTINUED STRATEGIC PATNERSHIPS
NDA INTRODUCES MOBILE MONEY PAYMENT SCHEME FOR NDAMIS GENERATED INVOICES
After successful roll out of NDAMIS system for managing most business processes, we are happy to introduce MM payment scheme
ISO/IEC 17025:2017 ACCREDITATION
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO/IEC 17025:2017 ACCREDITATION PAGE 2
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO/IEC 17025:2017 ACCREDITATION PAGE 3
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO 9001:2015 CERTIFICATION
National Drug Authority is ISO 9001:2015 Certified
NATIONAL DRUG AUTHORITY QUALITY POLICY
National Drug Authority (NDA) is committed to providing the highest standard of drug regulatory service to all customers.
* Click on the link to download
- National Drug Authority statement on conduct of Clinical Trials during the COVID-19 lockdown
- Guidance on the attributes of a valid proforma invoice when importing unregistered drugs
- Emergency use of Remdesivir in the context of the Covid-19 Pandemic
- Pharmacovigilance requirements for Remdesivir products under emergency importation
- Requirement for a Pharmacovigilance system for licensed persons in Uganda
- Provisions for emergency importation of Remdesivir in the context of the COVID-19 Pandemic
- Extension of the deadline for submission of CTD dossiers for renewal of registration
- Retention of products for the financial year 2020 / 2021
- Analysis for Nitrosamine impurities in drugs
- Communication circular on Clinical Trial new format for CT certificates
* Click on the link to download
- Pharmacovigilance Bulletin Volume 13, Issue 2, June 2021
- Pharmacovigilance Bulletin Volume 12: issue 4
- Veterinary Medicines Updates Bulletin Issue 5 June 2020
- Pharmacovigilance Bulletin June 2020
- Product applications with incomplete submission recommended for dismissal
- NDA PV bulletin Volume 11, issue 4 December 2019
- ADR Report - October - December 2019
- Pharmacovigilance Bulletin September 2019
- NDA PV bulletin June 2019
- NDA-PV bulletin - April 2019
- Frequently Asked Questions about National Drug Authority
- NDA-PV bulletin-Jan 2018
* Click on the link to download
- Public notice on tested hand sanitizers as at September 15th 2020 (updated)
- Public notice on tested hand sanitizers as at June 8th 2020 (updated)
- Public notice on tested hand sanitizers as at May 15th 2020
- Public Warning : Adulterated & substandard herbal products on the market – Embaluka hardcore drink & Megapower
- Public notice on Authorized sanitizers April 2020
Veterinary Drugs
For guaranteed animal safety, health and production.
Use Veterinary Drugs responsibly
LATEST NEWS
Get the very latest happening at the Uganda National Drug Authority daily
NDA undertakes a Pharmaceutical Inspection Co-operation Scheme (PIC/S) pre-assessment audit of its inspectorate system to determine its level of preparedness for the on-site audit by the PIC/S auditors.
The two weeks assessment by a team of experts from Europe will review NDA’s inspectorate quality management systems, quality control…
Launch of assessment and training packages for the occupation of Herbalists
The Directorate of Industrial Training in partnership with National Drug Authority today launched the assessment and training packages for the…
Annual Pharmacovigilance stakeholders round table meeting at Golf Course hotel
The Annual Pharmacovigilance meeting was held at Golf Course hotel today from 8.00am – 1.00pm and it was on discussing…
NDA Adverse Drug Reporting System
Pharmacovigilance in general if done poorly, adversely affects the quality, safety and efficacy of drugs as well as public health in general
